🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Concepción F. Estívariz

Centers for Disease Control and Prevention

ORCID: 0000-0003-1490-445X

Also affiliated with Center for Global Health

MedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial”.

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00139-1
N/A
1.4DataRank · unranked
24 citations

Khalequ Zaman, Masuma Hoque, Concepción F. Estívariz, Cara C. Burns, Jennifer L. Konopka‐Anstadt +15 more

Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial

The Lancet Microbe(2023)10.1016/s2666-5247(23)00215-x
N/A
0.165DataRank · unranked
2 citations

Harish Verma, Concepción F. Estívariz, Luna Bajracharaya, Ganesh Rai, Ganesh Shah +8 more

Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial

Vaccine(2024)10.1016/j.vaccine.2024.126216
N/A
0.129DataRank · unranked
1 citations

Khalequ Zaman, Concepción F. Estívariz, Asma Binte Aziz, Mohammad Yunus, Warda Haque +7 more

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial

Vaccine(2021)10.1016/j.vaccine.2021.08.065
N/A
0DataRank · unranked
9 citations

Stéphanie Kovacs, Kristin VanderEnde, Asma Binte Aziz, Mohammed Yunus, Sara Khan +7 more

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks

Vaccine(2022)10.1016/j.vaccine.2022.03.027
N/A
0DataRank · unranked
29 citations

Stéphanie Kovacs, Ondrej Mach, Concepción F. Estívariz